Skip to content

Clinical evaluation of the Articulinx Implant for the Carpometacarpal Joint.

Clinical evaluation of the Articulinx Implant for the Carpometacarpal Joint. - Articulinx CMC study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35298
Enrollment
20
Registered
2009-11-10
Start date
2009-11-11
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rizarthrosis thumbarthritis

Interventions

Sponsors

Articulinx
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adults between ages 40-75 with stage I or II osteoarthritis (according to Eaton Littler classification) of the CMC I joint. Subluxation less than 1/3 of the joint. Patients who are capable of providing informed consent and willing to adhere to the follow up schedule.

Exclusion criteria

Exclusion criteria: Significant and affecting pathology of the radial side of the hand and wrist. Significant osteophytes of the CMC I joint. Metabolic disorders of the bone. Prior surgery that precludes placement. Participating in another study. Pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
Incidence of device and procedure related adverse events.

Secondary

MeasureTime frame
Average pain score post procedure compared to pre operative baseline. Change in pain medication use ( taken specifically for the hand) compared to pre operative baseline. Change in joint function post procedure compared to pre operative baseline.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)